Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Bottazzi, Barbara ^a   Santini, Laura ^b   Savino, Silvana ^b   Giuliani, Marzia M ^b   Dueñas Díez, Ana I ^c   Mancuso, Giuseppe ^d   Beninati, Concetta ^d   Sironi, Marina ^a   Valentino, Sonia ^a   Deban, Livija ^a,f   Garlanda, Cecilia ^a   Teti, Giuseppe ^d   Pizza, Mariagrazia ^b   Rappuoli, Rino ^b   Mantovani, Alberto ^a,e  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d UNIVERSITY OF MESSINA   (Italy)

^e HUMANITAS UNIVERSITY   (Italy)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENTRAXIN 3; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; IMMUNOLOGICAL ADJUVANT; MENINGOCOCCUS VACCINE; OVALBUMIN; SERUM AMYLOID P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG PROTEIN BINDING; FEMALE; IN VIVO STUDY; INFANT; MALE; MENINGOCOCCOSIS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; RAT; VACCINATION; ANIMAL; BIOSYNTHESIS; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; NEWBORN; VIROLOGY; WISTAR RAT;

BACTERIA (MICROORGANISMS); MUS; NEISSERIA; NEISSERIA MENINGITIDIS; OAT MOSAIC VIRUS; RATTUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL LOAD; C-REACTIVE PROTEIN; FEMALE; GENE EXPRESSION; IMMUNITY, HUMORAL; IMMUNITY, INNATE; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; MICE, KNOCKOUT; NEISSERIA MENINGITIDIS; OVALBUMIN; RATS; RATS, WISTAR; SERUM AMYLOID P-COMPONENT; VACCINATION;

EID: 84925583086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120807     Document Type: Article

References (79)

1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007; 369:2196-210. PMID: 17604802
2. Stephens DS. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine. 2009; 27 Suppl 2:B71-7. doi: 10.1016/j.vaccine.2009.04.070 PMID: 19477055
3. Tzeng YL, Stephens DS. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2000; 2:687-700. PMID: 10884620
4. Coureuil M, Join-Lambert O, Lecuyer H, Bourdoulous S, Marullo S, Nassif X. Mechanism of meningeal invasion by Neisseria meningitidis. Virulence. 2012; 3:164-72. doi: 10.4161/viru.18639 PMID: 22366962
5. Stephens DS. Conquering the meningococcus. FEMS Microbiol Rev. 2007; 31:3-14. PMID: 17233633
6. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine. 2012; 30 Suppl 2:B87-97. doi: 10.1016/j.vaccine.2012.01.033 PMID: 22607904
7. Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines-an unfinished story. The Lancet infectious diseases. 2010; 10:112-24. doi: 10.1016/S1473-3099(09)70324-X PMID: 20113980
8. Lo H, Tang CM, Exley RM. Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. The Lancet infectious diseases. 2009; 9:418-27. doi: 10.1016/S1473-3099(09)70132-X PMID: 19555901
9. Wong HE, Li MS, Kroll JS, Hibberd ML, Langford PR. Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica. PloS one. 2011; 6:e26130. doi: 10.1371/journal.pone.0026130 PMID: 22028815
10. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010; 11:785-97. doi: 10.1038/ni.1923 PMID: 20720586
11. Schneider MC, Exley RM, Ram S, Sim RB, Tang CM. Interactions between Neisseria meningitidis and the complement system. Trends Microbiol. 2007; 15:233-40. PMID: 17398100
12. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol. 2006; 177:501-10. PMID: 16785547
13. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog. 2010; 6:e1001027. doi: 10.1371/journal.ppat.1001027 PMID: 20686663
14. Bottazzi B, Doni A, Garlanda C, Mantovani A. An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm. Annu Rev Immunol. 2010; 28:157-83. doi: 10.1146/annurev-immunol-030409-101305 PMID: 19968561
15. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005; 23:337-66. PMID: 15771574
16. Mantovani A, Valentino S, Gentile S, Inforzato A, Bottazzi B, Garlanda C. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann N Y Acad Sci. 2013; 1285:1-14. doi: 10.1111/nyas.12043 PMID: 23527487
17. Inforzato A, Baldock C, Jowitt TA, Holmes DF, Lindstedt R, Marcellini M, et al. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem. 2010; 285:17681-92. doi: 10.1074/jbc.M109.085639 PMID: 20363749
18. Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007; 204:793-804. PMID: 17389238
19. Inforzato A, Doni A, Barajon I, Leone R, Garlanda C, Bottazzi B, et al. PTX3 as a paradigm for the interaction of pentraxins with the Complement system. Semin Immunol. 2013.
20. Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003; 33:465-73. PMID: 12645945
21. Deban L, Jarva H, Lehtinen MJ, Bottazzi B, Bastone A, Doni A, et al. Binding of the long pentraxin PTX3 to Factor H: Interacting domains and function in the regulation of complement activation. J Immunology. 2008; 181:8433-40. PMID: 19050261
22. Ma YJ, Doni A, Hummelshoj T, Honore C, Bastone A, Mantovani A, et al. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem. 2009; 284:28263-75. doi: 10.1074/jbc.M109.009225 PMID: 19632990
23. Ma YJ, Doni A, Skjoedt MO, Honore C, Arendrup M, Mantovani A, et al. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem. 2011; 286:3405-17. doi: 10.1074/jbc.M110.190637 PMID: 21106539
24. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity. 2005; 22:551-60. PMID: 15894273
25. Deban L, Castro Russo R, Sironi M, Moalli F, Scanziani M, Zambelli V, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol. 2010; 11:328-34. doi: 10.1038/ni.1854 PMID: 20208538
26. Braunschweig A, Jozsi M. Human pentraxin 3 binds to the complement regulator c4b-binding protein. PloS one. 2011; 6:e23991. doi: 10.1371/journal.pone.0023991 PMID: 21915248
27. Moalli F, Doni A, Deban L, Zelante T, Zagarella S, Bottazzi B, et al. Role of complement and Fc {gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood. 2010; 116:5170-80. doi: 10.1182/blood-2009-12-258376 PMID: 20829368
28. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature. 2008; 456:989-92. doi: 10.1038/nature07468 PMID: 19011614
29. Souza DG, Amaral FA, Fagundes CT, Coelho FM, Arantes RM, Sousa LP, et al. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol. 2009; 174:1309-18. doi: 10.2353/ajpath.2009.080240 PMID: 19286566
30. Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol. 2004; 75:649-56. PMID: 14726497
31. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002; 420:182-6. PMID: 12432394
32. Jaillon S, Moalli F, Ragnarsdottir B, Bonavita E, Puthia M, Riva F, et al. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity. 2014; 40:621-32. doi: 10.1016/j.immuni.2014.02.015 PMID: 24745336
33. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P, et al. DC-SIGN (CD209), Pentraxin 3 and Vitamin D Receptor gene variants associate with pulmonary tubercolosis risk in West-Africans. Genes and immunity. 2007; 8:456-67. PMID: 17611589
34. Chiarini M, Sabelli C, Melotti P, Garlanda C, Savoldi G, Mazza C, et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes and immunity. 2010; 11:665-70. doi: 10.1038/gene.2010.41 PMID: 20927127
35. Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med. 2014; 370:421-32. doi: 10.1056/NEJMoa1211161 PMID: 24476432
36. Gaziano R, Bozza S, Bellocchio S, Perruccio K, Montagnoli C, Pitzurra L, et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother. 2004; 48:4414-21. PMID: 15504871
37. D'Angelo C, De Luca A, Zelante T, Bonifazi P, Moretti S, Giovannini G, et al. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J Immunol. 2009; 183:4609-18. doi: 10.4049/jimmunol.0900345 PMID: 19734205
38. Moalli F, Paroni M, Veliz Rodriguez T, Riva F, Polentarutti N, Bottazzi B, et al. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol. 2011; 186:5425-34. doi: 10.4049/jimmunol.1002035 PMID: 21441447
39. Paroni M, Moalli F, Nebuloni M, Pasqualini F, Bonfield T, Nonis A, et al. Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy. J Infect Dis. 2013; 208:130-8. doi: 10.1093/infdis/jis636 PMID: 23087427
40. Sprong T, Peri G, Neeleman C, Mantovani A, Signorini S, van der Meer JW, et al. Ptx3 and C-Reactive Protein in Severe Meningococcal Disease. Shock. 2009; 31:28-32. doi: 10.1097/SHK.0b013e31817fd543 PMID: 18650775
41. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997; 272:32817-23. PMID: 9407058
42. Granoff DM, Welsch JA, Ram S. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun. 2009; 77:764-9. doi: 10.1128/IAI.01191-08 PMID: 19047406
43. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A. 2010; 107:3770-5. doi: 10.1073/pnas.0915162107 PMID: 20133713
44. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 2000; 287:1816-20. PMID: 10710308
45. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med. 2003; 197:789-99. PMID: 12642606
46. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics. 2006; 6:1856-66. PMID: 16456881
47. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 2000; 287:1809-15. PMID: 10710307
48. Seib KL, Oriente F, Adu-Bobie J, Montanari P, Ferlicca F, Giuliani MM, et al. Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection. Vaccine. 2010; 28:2416-27. doi: 10.1016/j.vaccine.2009.12.082 PMID: 20067752
49. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, Santini L, et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A. 2006; 103:10834-9. PMID: 16825336
50. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, et al. Antiviral Activity of the Long Chain Pentraxin PTX3 against Influenza Viruses. J Immunol. 2008; 180:3391-8. PMID: 18292565
51. Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine. 2009; 27 Suppl 2:B3-12. doi: 10.1016/j.vaccine.2009.04.071 PMID: 19481313
52. Du Clos TW, Marnell L, Zlock LR, Burlingame RW. Analysis of the binding of C-reactive protein to chromatin subunits. J Immunol. 1991; 146:1220-5. PMID: 1991964
53. Muzzi A, Mora M, Pizza M, Rappuoli R, Donati C. Conservation of Meningococcal Antigens in the Genus Neisseria. mBio. 2013; 4:e00163-13. doi: 10.1128/mBio.00163-13 PMID: 23760461
54. Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A. 2000; 97:14584-9. PMID: 11121061
55. Casey R, Newcombe J, McFadden J, Bodman-Smith KB. The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun. 2008; 76:1298-304. doi: 10.1128/IAI.00741-07 PMID: 18195032
56. Szalai AJ. The antimicrobial activity of C-reactive protein. Microbes Infect. 2002; 4:201-5. PMID: 11880053
57. Mosca F, Tritto E, Muzzi A, Monaci E, Bagnoli F, Iavarone C, et al. Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci U S A. 2008; 105:10501-6. doi: 10.1073/pnas.0804699105 PMID: 18650390
58. Welsch JA, Moe GR, Rossi R, Adu-Bobie J, Rappuoli R, Granoff DM. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. J Infect Dis. 2003; 188:1730-40. PMID: 14639545
59. Beninati C, Midiri A, Mancuso G, Biondo C, Arigo M, Gerace E, et al. Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci. J Exp Med. 2006; 203:111-8. PMID: 16390937
60. Jacobsson S, Hedberg ST, Mölling P, Unemo M, Comanducci M, Rappuoli R, et al. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine. 2009; 27:1579-84. doi: 10.1016/j.vaccine.2008.12.052 PMID: 19162117
61. Hill DJ, Griffiths NJ, Borodina E, Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond). 2010; 118:547-64. doi: 10.1042/CS20090513 PMID: 20132098
62. Vogel U, Frosch M. Mechanisms of neisserial serum resistance. Mol Microbiol. 1999; 32:1133-9. PMID: 10383755
63. Claus H, Maiden MC, Maag R, Frosch M, Vogel U. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology. 2002; 148:1813-9. PMID: 12055301
64. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, et al. Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine. Clin Vaccine Immunol. 2010; 17:919-29. doi: 10.1128/CVI.00027-10 PMID: 20375242
65. Pluddemann A, Hoe JC, Makepeace K, Moxon ER, Gordon S. The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia. PLoS Pathog. 2009; 5:e1000297. doi: 10.1371/journal.ppat.1000297 PMID: 19214213
66. Pluddemann A, Mukhopadhyay S, Sankala M, Savino S, Pizza M, Rappuoli R, et al. SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors. J Innate Immun. 2009; 1:153-63. doi: 10.1159/000155227 PMID: 20375573
67. Janeway CA Jr. How the immune system protects the host from infection. Microbes and Infection. 2001; 3:1167-71. PMID: 11709297
68. Schenten D, Medzhitov R. Chapter 3 - The Control of Adaptive Immune Responses by the Innate Immune System. In: Frederick WA, editor. Adv Immunol: Academic Press; 2011. p. 87-124. doi: 10.1016/B978-0-12-387664-5.00003-0 PMID: 21569913
69. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010; 327:291-5. doi: 10.1126/science.1183021 PMID: 20075244
70. Sprong T, Stikkelbroeck N, van der Ley P, Steeghs L, van Alphen L, Klein N, et al. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol. 2001; 70:283-8. PMID: 11493621
71. Uronen H, Williams AJ, Dixon G, Andersen SR, Van Der Ley P, Van Deuren M, et al. Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS). Clin Exp Immunol. 2000; 122:312-5. PMID: 11122234
72. Ingalls RR, Lien E, Golenbock DT. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2. Infect Immun. 2001; 69:2230-6. PMID: 11254578
73. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med. 2003; 197:1107-17. PMID: 12719479
74. Gout E, Moriscot C, Doni A, Dumestre-Perard C, Lacroix M, Perard J, et al. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules. J Immunol. 2011; 186:5815-22. doi: 10.4049/jimmunol.1100180 PMID: 21490156
75. Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence. 2014; 5:98-126. doi: 10.4161/viru.26515 PMID: 24104403
76. Mathew S, Overturf GD. Complement and properidin deficiencies in meningococcal disease. Pediatr Infect Dis J. 2006; 25:255-6. PMID: 16511390
77. Haralambous E, Dolly SO, Hibberd ML, Litt DJ, Udalova IA, O'Dwyer C, et al. Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis. 2006; 38:764-71. PMID: 16938729
78. Moya-Quiles MR, Bernardo-Pisa MV, Martínez P, Gimeno L, Bosch A, Salgado G, et al. Complement component C6 deficiency in a Spanish family: Implications for clinical and molecular diagnosis. Gene. 2013; 521:204-6. doi: 10.1016/j.gene.2013.03.027 PMID: 23537992
79. Schejbel L, Fadnes D, Permin H, Lappegard KT, Garred P, Mollnes TE. Primary complement C5 deficiencies - Molecular characterization and clinical review of two families. Immunobiology. 2013.